Abstract: A method of lowering intraocular pressure (IOP) employs an upregulating agent that induces increased prostaglandin synthesis in the eye. The method of treatment entails administering to the eye of a mammal in need thereof a prostaglandin upregulating agent to increase endogenous prostaglandin synthesis and thereby effect a reduction in intraocular pressure. In a preferred embodiment the upregulating agent is IL-1.
Abstract: Topically administrable anti-allergy compositions comprising olopatadine and a polymeric quaternary ammonium preservative are suitable for use by patients wearing contact lenses.
Abstract: Methods and compositions for preventing or treating allergic diseases of the eye, nose, skin, ear, gastrointestinal tract, airways or lung and preventing or treating manifestations of systemic mastocytosis are disclosed. The compositions contain a mast cell stabilizing disulfide derivative as an active ingredient.
Type:
Grant
Filed:
April 25, 2001
Date of Patent:
April 16, 2002
Assignee:
Alcon Universal Ltd.
Inventors:
Mark R. Hellberg, Zixia Feng, Steven T. Miller
Abstract: Water-soluble borate-polyol complexes are useful as buffers and/or antimicrobials in aqueous ophthalmic compositions, including those containing polyvinyl alcohol. These compositions have greater antimicrobial activity than comparable compositions containing typical borate buffers and unexpectedly increase the antimicrobial efficacy of other antimicrobial agents when used in combination. In addition, use of the borate-polyol complexes avoids the incompatibility problem typically associated with the combination of borate buffer and polyvinyl alcohol; therefore, the compositions disclosed herein may also contain polyvinyl alcohol.
Type:
Grant
Filed:
June 20, 2000
Date of Patent:
April 2, 2002
Assignee:
Alcon Manufacturing, Ltd.
Inventors:
Masood Chowhan, Nissanke L. Dassanayake
Abstract: This invention is directed toward a topical composition comprising ciprofloxacin and hydrocortisone, where the composition contains a specific grade of polyvinyl alcohol as a viscosity augmenter. The specified grade of polyvinyl alcohol is 85-90% hydrolyzed polyvinyl alcohol.
Type:
Application
Filed:
July 16, 2001
Publication date:
March 28, 2002
Applicant:
Alcon Universal Ltd.
Inventors:
Onkar N. Singh, Haresh G. Bhagat, Bhagwati P. Kabra
Abstract: Stable aqueous pharmaceutical suspension compositions containing lecithin as a stabilizing additive and lacking a polymeric suspending agent are disclosed.
Abstract: This invention is directed toward a method of preparing a topical composition comprising ciprofloxacin and hydrocortisone. The method involves dispersing hydrocortisone with lecithin for greater than 45 minutes prior to combining hydrocortisone with the balance of the composition.
Abstract: The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat angiogenesis-related disorders, including ophthalmic angiogenesis-related disorders such as diabetic retinopathy and exudative macular degeneration, is disclosed.
Type:
Application
Filed:
August 13, 2001
Publication date:
March 28, 2002
Applicant:
Alcon Universal Ltd.
Inventors:
Michael A. Kapin, David P. Bingaman, Daniel A. Gamache, Gustav Graff, John M. Yanni
Abstract: Topically administrable aqueous solution compositions containing tobramycin and xanthan gum are disclosed. The solution compositions contain a buffering agent and a pH-adjusting agent in an amount sufficient to achieve a pH above 7.8 in order to minimize or avoid compatibility problems between tobramycin and xanthan gum.
Type:
Application
Filed:
July 11, 2001
Publication date:
March 21, 2002
Applicant:
Alcon Universal Ltd.
Inventors:
Nuria Carreras Perdiguer, Jose Alberto Vallet Mas, Gemma Torrella Cabello
Abstract: A microsurgical instrument having a handle and a dissecting tip coupled to the handle is disclosed. The handle includes a cannula for transporting surgical fluid. The dissecting tip includes a blade for dissecting tissue and an aperture for delivering the fluid. The instrument may be used to more effectively create an intracorneal pocket for the implantation of an intracorneal optical lens.
Type:
Grant
Filed:
December 20, 1999
Date of Patent:
March 19, 2002
Assignee:
Alcon Universal Ltd.
Inventors:
Kwan Y. Chan, Gregory S. Milios, David E. Booth, Dyson W. Hickingbotham
Abstract: A microsurgical instrument that includes a handle and a dissecting tip coupled to the handle is disclosed. The tip includes a blade having a generally elliptical three-dimensional geometry. The blade may include an edge having a first arc and an opposing second arc. When the instrument is used to form an intracorneal pocket for the implantation of an intracorneal optical lens, the curvature of the first arc allows the edge to dissect a first blind spot of the pocket, and the curvature of the second arc allows the edge to dissect a second blind spot of the pocket. The blade may also be formed with a first depression in its top surface and a second depression in its bottom surface. When the instrument is used to form an intracorneal pocket, the depressions reduce the drag on, and corresponding trauma to, stromal tissue.
Type:
Grant
Filed:
November 5, 1999
Date of Patent:
March 19, 2002
Assignee:
Alcon Universal Ltd.
Inventors:
Kwan Y. Chan, Gregory S. Milios, David E. Booth, Dyson W. Hickingbotham
Abstract: Improved stability, liquid enzyme compositions containing an alkylated trypsin and methods involving the combined use of these compositions with an aqueous composition are disclosed for the cleaning or simultaneous cleaning and disinfecting of contact lens. Methods for a daily use regimen are also disclosed.
Type:
Grant
Filed:
September 1, 1998
Date of Patent:
March 19, 2002
Assignee:
Alcon Laboratories, Inc.
Inventors:
Bor-Shyue Hong, Bahram Asgharian, Ronald P. Quintana
Abstract: Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically stable and easily re-suspended. The formulations are intended for topical application to the eye, ear or nose.
Abstract: The application of switchable tackiness coating compositions to ophthalmic implants provides the benefits of body temperature tackiness without the disadvantages of room temperature tackiness.
Type:
Application
Filed:
August 24, 2001
Publication date:
March 7, 2002
Applicant:
Alcon Universal Ltd.
Inventors:
Anilbhai S. Patel, Douglas C. Schlueter, Mutlu Karakelle
Abstract: Compositions containing one or more HETE derivative(s) and an effective concentration of ethanol and methods of use for treating dry eye are disclosed.
Type:
Grant
Filed:
October 23, 2000
Date of Patent:
March 5, 2002
Assignee:
Alcon Universal Ltd.
Inventors:
L. Wayne Schneider, Daniel A. Gamache, Lori K. Weimer, Timothy L. Kessler, Zhongyou Wei, Terri Pasquine, John M. Yanni, Haresh G. Bhagat
Abstract: A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I:
Type:
Grant
Filed:
June 2, 1999
Date of Patent:
March 5, 2002
Assignee:
Alcon Laboratories, Inc.
Inventors:
Verney L. Sallee, Mark R. Hellberg, Peter G. Klimko, Paul W. Zinke
Abstract: Topically administrable aqueous solution compositions containing tobramycin and xanthan gum are disclosed. The solution compositions contain a buffering agent and a pH-adjusting agent in an amount sufficient to achieve a pH above 7.8 in order to minimize or avoid compatibility problems between tobramycin and xanthan gum.
Type:
Grant
Filed:
July 11, 2001
Date of Patent:
March 5, 2002
Assignee:
Alcon Universal Ltd.
Inventors:
Nuria Carreras Perdiguer, Jose Alberto Vallet Mas, Gemma Torrella Cabello